Skip to main content
. 2020 Oct 26;35(Suppl 2):839–848. doi: 10.1007/s11606-020-06102-8

Table 2.

Demographics and Outcomes for Collaborative Care for the Kaiser Permanente Southern California (KPSC) Depression Care Management (DCM) Initiative Across Time

2015 2016 2017 2018
Patients newly diagnosed with depression (NDD) in adult primary care (APC) 45,535 56,641 63,843 71,257
Patients NDD in APC with PHQ-9, %(n) 10.7 (4871) 18.0 (10,221) 37.1 (23,691) 50.9 (36,307)
Referrals to psychiatry for patients NDD, % (n) 5.7 (2598) 5.5 (3100) 6.4 (4077) 7.5 (5323)
Patients NDD in APC with PHQ-9 total score 10–19 (eligible for DCM program) 2650 5195 11,373 16,304
Patients enrolled in the DCM program (n) 3270 3751 4826 5205
Women, % (n) 73 (2376) 72 (2711) 76 (3642) 76 (3979)
Race/ethnicity, % (n)
Hispanic 51 (1660) 45 (1702) 44 (2108) 47 (2427)
White 33 (1071) 36 (1349) 36 (1756) 34 (1766)
Black 9 (278) 10 (388) 11 (533) 10 (539)
Asian 5 (174) 5 (187) 5 (255) 4 (217)
Other 3 (87) 3 (125) 4 (174) 5 (256)
Language spoken, % (n)
English 79 (2591) 81 (3033) 85 (4110) 84 (4375)
Spanish 20 (655) 18% (686) 14 (686) 15 (810)
Other 1 (24) 1 (32) 1 (30) 1 (20)
Age (years) 56.3 ± 16.8 54.8 ± 17.5 53.6 ± 17.8 51.1 ± 18.3
18–29, % (n) 7 (243) 10 (390) 12 (568) 16 (819)
30–64, % (n) 58 (1907) 59 (2213) 58 (2810) 57 (2985)
65+, % (n) 34 (1120) 31 (1148) 30 (1448) 27 (1401)
PHQ-9 total score at enrollment 12 ± 6 12 ± 5 13 ± 5 13 ± 4
PHQ-9 < 5, % (n) 14 (458) 7 (275) 3 (127) 3 (141)
PHQ-9 5–9, % (n) 8 (249) 18 (682) 19 (896) 13 (697)
PHQ-9 10–19, % (n) 71 (2307) 67 (2526) 71 (3434) 78 (4064)
PHQ-9 20+, % (n) 8 (256) 7 (268) 8 (369) 6 (303)
Months of treatment for discharged patients 5.1 ± 6.7 [n = 3213] 5.6 ± 6.9 [n = 3741] 5.3 ± 4.2 [n = 4787] 4.6 ± 3.0 [n = 4920]
< 1, % (n) 21 (668) 15 (578) 6 (269) 6 (272)
1–3, % (n) 36 (1153) 33 (1222) 29 (1370) 30 (1455)
3–6, % (n) 17 (547) 23 (868) 33 (1570) 38 (1878)
6–12, % (n) 15 (466) 16 (600) 25 (1190) 24 (1189)
12+, % (n) 12 (379) 13 (473) 8 (388) 3 (126)
Patients taking antidepressants during the DCM program, % (n) 56.0 (1830) 59.2 (2221) 60.4 (2913) 59.6 (3103)
Patients engaged while in the DCM program*, % (n) 41.8 (1370) 54.4 (2040) 69.0 (3333) 73.7 (3837)
Depression symptom improvement at discharge from DCM program, % (n) 54 (592) [n = 1101] 55 (848) [n = 1548] 56 (1397) [n = 2490] 62 (1678) [n = 2727]
Depression symptom remission at discharge from the DCM program, % (n) 37 (411) [n = 1101] 38 (596) [n = 1548] 41 (1033) [n = 2490] 45 (1235) [n = 2727]
Depression symptom improvement at 6 months after discharge from the DCM program, % (n) 70 (138) [n = 197] 59 (297) [n = 505] 61 (777) [n = 1276] 61 (693) [n = 1132]
Depression symptom remission at 6 months after discharge from the DCM program, % (n) 56 (110) [n = 197] 43 (218) [n = 505] 48 (615) [n = 1276] 47 (536) [n = 1132]

*Engagement in treatment was defined as patients who had at least two PHQ-9 assessments following the enrollment PHQ-9 for at least 3 months of treatment (at least three PHQ-9 measures in total)

Depression symptom improvement was defined as having at least a 50% reduction in the PHQ-9 total score at discharge compared with the enrollment total score. Only patients with a PHQ-9 total score of 10+ who were discharged after at least 3 months of treatment were considered for improvement outcomes

Depression symptom remission was defined as having a PHQ-9 total score at discharge < 5. Only patients with a PHQ-9 total score of 10+ who were discharged after at least 3 months of treatment were considered for improvement outcomes